(CercleFinance.com) – Visiomed Group signed one of the biggest increases on the Parisian market on Tuesday after reporting ‘record’ results for the 2023 financial year, a performance which, according to it, confirms the existence of a ‘new dynamic’ ‘.
For the first time in its stock market history, the connected health specialist says it has generated ‘tangible’ and ‘recurring’ turnover and operating profit.
Smart Salem, its network of digital medical analysis centers present in the Middle East, saw its turnover increase by 38% to 13.7 million euros last year.
Current operating profit (Ebitda) reached a record level of 3.5 million euros in normalized data and 2.2 million euros in consolidated data, giving a positive net profit of 1.1 million euros.
Visiomed also mentions increasing gross cash flow and ‘controlled’ net debt of five million euros, while highlighting 2024 prospects in line with its ‘very positive’ trajectory.
The group says it is confident in its ability to sustain its growth and profitability in 2024 thanks to the performance of Smart Salem, structural costs still under control and an acceleration of its project in Saudi Arabia.
On the Paris Stock Exchange, Visiomed shares rose by more than 7% on Tuesday morning following all these announcements. The value still shows a decline of 18% since the start of the year.
Copyright (c) 2024 CercleFinance.com. All rights reserved.
Are you following this action?
Receive all the information on VISIOMED GROUP in real time: